CD8-β Antibodies

Santa Cruz Biotechnology offers a broad range of CD8-β monoclonal antibodies for immunology and cell biology research. CD8-β monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD8-β is a critical component of the CD8 glycoprotein complex, which plays a vital role in the immune response by aiding in the recognition of antigens presented by MHC class I molecules. CD8-β is primarily expressed on cytotoxic T cells, which are essential for the elimination of infected or malignant cells. Understanding the function and regulation of CD8-β is crucial for advancing therapeutic strategies in cancer immunotherapy and infectious disease management. Research focusing on CD8-β expression patterns helps reveal important insights into T cell development and activation. Investigating CD8-β interactions with other immune molecules provides valuable information about cellular immune responses. CD8-β research continues to unlock new possibilities in immunology and disease treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of immune system function and disease mechanisms.